Embodiments relate to a liner for use with a respiratory mask, such as a CPAP mask.
Obstructive sleep apnea is a serious and potentially fatal medical condition in which a person's airway becomes physically blocked multiple times during sleep, restricting oxygen intake and causing the person to awake gasping for breath. Possible effects of the condition include extreme fatigue, high blood pressure, strokes, heart attacks, and sometimes even death.
One of the most common treatments of obstructive sleep apnea is the use of a continuous positive airway pressure (CPAP) machine. These machines deliver a continuous flow of pressurized air to the airway through a hose and mask fitted to the face. Patient compliance is a major problem with CPAP users, however, due to discomfort, air leaks, and general ineffectiveness. It is estimated that up to 50% of users discontinue use.
Most CPAP masks currently available are made from silicone, rubber, vinyl, or a nylon-based fabric. These materials are typically water and gas impermeable, which can block off pores, cause sweating, and create pressure marks on the face, increasing the discomfort of the mask. Furthermore, most mask manufacturers recommend against the use of skin or face cream with CPAP masks since the mask material directly contacts the skin. This is a problem for many users, especially those that have dry skin and depend on night cream for skin care.
As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention that may be embodied in various and alternative forms. The figures are not necessarily to scale; some features may be exaggerated or minimized to show details of particular components. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a representative basis for teaching one skilled in the art to variously employ the present invention.
One or more embodiments disclosed herein provide an accessory capable of improving the comfort, effectiveness, and/or patient compliance of CPAP and other respiratory masks.
With reference to
In one embodiment, the liner 10 includes a body 12 having an outer edge 14, an inner edge 16, and an opening 18 bounded by the inner edge 16. The body 12 may be generally oval-shaped, elliptical, round, or triangular, or have any other shape appropriate for use with a respiratory mask, and is not limited to those shapes depicted herein. The opening 18 is configured to at least partially receive the nose, mouth, or both nose and mouth, depending upon the type of mask, allowing air flow from an air source to be received by the user through the mask M. The opening 18 may be generally elliptical or oval-shaped as shown, but is not intended to be limited to these shapes.
Referring to
In one embodiment, the outer edge 14 may extend beyond the perimeter of the mask face-engaging portion F by between about 0.25 to 1.0 inches, or more particularly may extend between about 0.5 and 0.75 inches. In general, the area of the extending portion 22 may comprise at least about 5%, 10%, or 15% of the area of the body 12, but larger proportions of area represented by the extending portion 22 are also contemplated. By allowing the outer edge 14 of the liner 10 to loosely protrude beyond the mask M, the extending portion 22 is configured to be in non-adhering communication with a user's face and serves to reduce air leaks from the perimeter of the mask M by acting as a baffle to regulate, limit, or diffuse air flow between the mask M and the skin, thus also stopping any resulting squealing-type noises created by such air leaks.
According to an embodiment, the body 12 is constructed from a single layer of absorbent material, wherein the thickness of the body 12 may be between about 0.005 to 0.05 inches, although these dimensions are not intended to be limiting. In one embodiment, the material may include cotton. In another embodiment, the material may include another material, such as silicone, with cotton embedded therein. However, it is understood that any material with suitable absorption and comfort properties may be used. In further accordance with an embodiment, the material used for the construction of the body 12 may be stretchable to aid in adjusting and customizing the fit of the liner 10 to a particular user as described below. The absorbent material may function to absorb moisture and/or oils from the user's skin and enable the mask M to maintain a consistent and comfortable position with respect to the user's face when in use.
In a CPAP system, an air source (not shown) delivers a constant flow of pressurized and humidified air to the CPAP mask M. Due to the moisture of the humidified air, facial perspiration (such as due to contact with the mask material), and oil from the skin, the mask M may slip on the user's face, thus leaking air and awakening the user during sleep. The liner 10 may absorb such moisture and wick it away from the face and mask surfaces. As a result, proper positioning of the mask M with respect to the skin may be maintained, thus eliminating or greatly reducing air leaks and facilitating the ability for a user to wear their CPAP mask successfully throughout the night.
The single layer construction of the liner 10 may act as a sort of “second skin” upon the user's face. As such, the liner 10 is able to provide its baffle function without detracting from the prescribed fit of the mask M since the liner 10 does not appreciably alter the distance of the face-engaging portion F from the user's face. Pressure markings from the mask M may also be reduced or eliminated by use of the liner 10. Furthermore, the absorbent liner material may make use of facial creams possible while wearing the mask M, since direct contact of the skin with the mask material is avoided.
According to an embodiment, the liner 10 is held in place by the pressure of the respiratory mask M upon the face (e.g., by straps around the head). While it is contemplated that the liner 10 could be at least partially fastened to the mask M, advantageously neither elastic nor another mechanism for securing the liner 10 to the mask M is required, allowing for ease of use and manufacture. The position of the liner 10 can be adjusted if necessary while the mask M is secured, and the liner 10 is easily removable and replaceable when the mask M is removed.
Respiratory masks, more particularly CPAP masks, are offered in various shapes and sizes, including full-face, nasal, child-sized, and partial-face (hybrid) configurations. Full-face masks typically include a wider bottom region for covering the mouth area and a narrower upper region for covering the nasal area. Nasal masks generally cover the nasal area and not the mouth area. Child-sized masks may have a proportionally smaller size. Partial-face (hybrid) masks generally cover the mouth and may include a nasal interface. It is therefore contemplated that the outer edge 14 of liner 10 may have a shape similar to a general shape of the face-engaging portion F for a selected mask M, wherein the shape of the outer edge 14 may represent a scaled version of the general shape of the face-engaging portion F.
If the liner 10 is to be used with a full-face CPAP mask, the opening 18 may be sized to at least partially receive the user's nose and mouth (see
Turning to
Referring now to
In another embodiment, a liner 100 as illustrated in
In another embodiment, which may be for use with a nasal pillow mask, the liner 100 may include an additional aperture 124 sized for placement over the hose connection of the mask for possible added stability. In this embodiment, the second pair of apertures 120 may be disposed more centrally along the length of the liner 100.
For a hybrid face-nasal pillow mask, the embodiment of
In the embodiment of
In use, the liners 100, 200 may be positioned between and held in place by the respiratory mask and the face of a user in order to absorb moisture, maintain proper positioning of the mask, and greatly reduce or eliminate air from leaking between the mask and the user's face. A perimeter of the liner outer edge 114, 214, which may be continuous or discontinuous, is larger than a perimeter of the face-engaging portion (including nasal pillows) of the mask, wherein the liners 100, 200 are configured to be releasably held between the mask and a user's face such that the outer edge 114, 214 extends beyond the mask face-engaging portion around at least part of its perimeter. As such, the body 112, 212 has an extending portion outward of the perimeter of the face-engaging portion. By allowing the outer edge 114, 214 of the liner 100, 200 to loosely protrude beyond the mask, the extending portion is configured to be in non-adhering communication with a user's face and serves to reduce air leaks from the perimeter of the mask by acting as a baffle to regulate, limit, or diffuse air flow between the mask and the skin, thus also stopping any resulting squealing-type noises created by such air leaks. It is understood that the other features described above with reference to liner 10 may also be applicable to liners 100, 200.
With reference to
With reference to
In another embodiment, a liner 300 as illustrated in
The body 312 may be generally oval-shaped, elliptical, round, triangular, or rectangular, or have any other shape appropriate for use with a respiratory mask, and is not limited to the shape depicted herein. The apertures 350, 352, 354 and 356 may be generally circular or elongate or oval-shaped as shown, but are not intended to be limited to these shapes. With reference to
In use, the liner 300 may be positioned between and held in place by the respiratory mask and the face of a user in order to absorb moisture, maintain proper positioning of the mask, and greatly reduce or eliminate air from leaking between the mask and the user's face. A perimeter of the liner outer edge 314, which may be continuous or discontinuous, is larger than a perimeter of the face-engaging portion of the mask, wherein the liner 300 is configured to be releasably held between the mask and a user's face such that the outer edge 314 extends beyond the mask face-engaging portion around at least part of its perimeter. As such, the body 312 has an extending portion outward of the perimeter of the face-engaging portion. By allowing the outer edge 314 of the liner 300 to loosely protrude beyond the mask, the extending portion is configured to be in non-adhering communication with a user's face and serves to reduce air leaks from the perimeter of the mask by acting as a baffle to regulate, limit, or diffuse air flow between the mask and the skin, thus also stopping any resulting squealing-type noises created by such air leaks. It is understood that the other features described above with reference to liners 10, 100 and 200 may also be applicable to liner 300.
With reference to
Copper is a natural mineral having human nutritional benefit. Copper is also known to provide antimicrobial and potential wound healing properties. In one embodiment, the liners 10, 100, 200, 300 described herein may be manufactured with a copper or copper oxide material, such as CUPRON®.
CPAP therapy is the most widely used method for treating sleep apnea, but it is only successful when the equipment fits and works properly and allows the user to stay asleep and experience deep-sleep, rapid eye movement (REM) cycles, the sleep cycle in which the most beneficial rest takes place. The liners 10, 100, 200, 300 may facilitate a more comfortable and effective CPAP therapy by contributing to a good fit of the CPAP mask M, providing comfort to the user, and reducing or eliminating air leaks, thus resulting in less disruption of sleep.
While exemplary embodiments are described above, it is not intended that these embodiments describe all possible forms of the invention. Rather, the words used in the specification are words of description rather than limitation, and it is understood that various changes may be made without departing from the spirit and scope of the invention. Additionally, the features of various implementing embodiments may be combined to form further embodiments of the invention.
This application is a continuation-in-part of U.S. application Ser. No. 13/758,783 filed Feb. 4, 2013, now U.S. Pat. No. 9,113,667, which is a continuation-in-part of U.S. application Ser. No. 12/469,998 filed May 21, 2009, now U.S. Pat. No. 8,365,733, which, in turn, claims the benefit of U.S. provisional Application No. 61/056,893 filed May 29, 2008, the disclosures of which are incorporated in their entirety by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
1990199 | Nemzek | Feb 1935 | A |
2008677 | Booharin | Jul 1935 | A |
2435721 | Lehmann | Feb 1948 | A |
2931356 | Schwartz | Apr 1960 | A |
3130722 | Etal | Apr 1964 | A |
3357426 | Cohen | Dec 1967 | A |
4069516 | Watkins, Jr. | Jan 1978 | A |
D257063 | Galindo | Sep 1980 | S |
4856508 | Tayebi | Aug 1989 | A |
5003633 | Itoh | Apr 1991 | A |
5146914 | Sturrock | Sep 1992 | A |
5243971 | Sullivan et al. | Sep 1993 | A |
5921239 | McCall et al. | Jul 1999 | A |
6016805 | Burns et al. | Jan 2000 | A |
6082360 | Rudolph et al. | Jul 2000 | A |
6196223 | Belfer et al. | Mar 2001 | B1 |
D442352 | Benjamin et al. | May 2001 | S |
6338340 | Finch et al. | Jan 2002 | B1 |
6468222 | Mault et al. | Oct 2002 | B1 |
6629531 | Gleason et al. | Oct 2003 | B2 |
6698427 | Clowers | Mar 2004 | B1 |
6698727 | Shaw | Mar 2004 | B1 |
6851429 | Bishop | Feb 2005 | B2 |
6926004 | Schumacher | Aug 2005 | B2 |
6955650 | Mault et al. | Oct 2005 | B2 |
7000614 | Lang et al. | Feb 2006 | B2 |
7017577 | Matich | Mar 2006 | B2 |
7077138 | Bateman et al. | Jul 2006 | B2 |
7178525 | Matula, Jr. et al. | Feb 2007 | B2 |
7219670 | Jones, Jr. et al. | May 2007 | B2 |
7234466 | Kwok et al. | Jun 2007 | B2 |
7243650 | Thornton | Jul 2007 | B2 |
7296574 | Ho et al. | Nov 2007 | B2 |
7370652 | Matula, Jr. et al. | May 2008 | B2 |
7427703 | Geier | Sep 2008 | B2 |
D644729 | Ferris et al. | Sep 2011 | S |
8171934 | Ho | May 2012 | B1 |
8365733 | Rutan | Feb 2013 | B2 |
D717939 | Koehler | Nov 2014 | S |
D735318 | Roblin-Lee | Jul 2015 | S |
D738514 | Tagami et al. | Sep 2015 | S |
D755951 | Roblin-Sharp | May 2016 | S |
20030023182 | Mault et al. | Jan 2003 | A1 |
20040194784 | Bertrand | Oct 2004 | A1 |
20040244799 | Landis | Dec 2004 | A1 |
20040244804 | Olsen et al. | Dec 2004 | A1 |
20040261797 | White et al. | Dec 2004 | A1 |
20050199239 | Lang et al. | Sep 2005 | A1 |
20050268907 | McFarlane | Dec 2005 | A1 |
20050279367 | Klemperer | Dec 2005 | A1 |
20050284481 | Meyer et al. | Dec 2005 | A1 |
20060060200 | Ho et al. | Mar 2006 | A1 |
20060081251 | Hernandez et al. | Apr 2006 | A1 |
20060107431 | Curran et al. | May 2006 | A1 |
20060130845 | Schegerin | Jun 2006 | A1 |
20060144399 | Davidowski et al. | Jul 2006 | A1 |
20060283452 | Woodard et al. | Dec 2006 | A1 |
20070006879 | Thornton | Jan 2007 | A1 |
20070017525 | Madaus et al. | Jan 2007 | A1 |
20070050883 | Matich | Mar 2007 | A1 |
20070157934 | Lang et al. | Jul 2007 | A1 |
20070175479 | Groll | Aug 2007 | A1 |
20070175480 | Gradon et al. | Aug 2007 | A1 |
20080047560 | Veliss et al. | Feb 2008 | A1 |
20080110469 | Weinberg | May 2008 | A1 |
20080127984 | Thornton | Jun 2008 | A1 |
20080257354 | Davidson et al. | Oct 2008 | A1 |
20080302365 | Cohen et al. | Dec 2008 | A1 |
20090050144 | Pierce et al. | Feb 2009 | A1 |
20090107507 | Moore | Apr 2009 | A1 |
20090139525 | Schirm | Jun 2009 | A1 |
20090211581 | Bansal | Aug 2009 | A1 |
20090293880 | Rutan | Dec 2009 | A1 |
20100031958 | Stewart | Feb 2010 | A1 |
20100326445 | Veliss et al. | Dec 2010 | A1 |
20110005524 | Veliss et al. | Jan 2011 | A1 |
20110061656 | Matich | Mar 2011 | A1 |
20110226240 | Navalesi et al. | Sep 2011 | A1 |
20120080035 | Guney et al. | Apr 2012 | A1 |
20120180795 | Knight | Jul 2012 | A1 |
20120204881 | Davidson et al. | Aug 2012 | A1 |
20130139290 | Barski | Jun 2013 | A1 |
20130139829 | Rutan | Jun 2013 | A1 |
20140150799 | Daly | Jun 2014 | A1 |
20140190492 | Noh et al. | Jul 2014 | A1 |
20140345621 | Zack et al. | Nov 2014 | A1 |
20150352309 | Daly | Dec 2015 | A1 |
20150374943 | Alexani | Dec 2015 | A1 |
20150374945 | Anthony | Dec 2015 | A1 |
20160279359 | Chang et al. | Sep 2016 | A1 |
20160339196 | Bowsher | Nov 2016 | A1 |
20170049983 | Ellis | Feb 2017 | A1 |
Number | Date | Country |
---|---|---|
1681551 | Oct 2005 | CN |
1681553 | Oct 2005 | CN |
101653632 | Feb 2010 | CN |
102065786 | May 2011 | CN |
102448550 | May 2012 | CN |
162526 | May 1921 | GB |
4420956 | Sep 1969 | JP |
S4420956 | Sep 1969 | JP |
S05014702 | May 1975 | JP |
61185446 | Nov 1986 | JP |
S61185446 | Nov 1986 | JP |
05051364 | Jul 1993 | JP |
2000217940 | Aug 2000 | JP |
2003501220 | Jan 2003 | JP |
2003052845 | Feb 2003 | JP |
2003052845 | Feb 2003 | JP |
2005537904 | Dec 2005 | JP |
20100003822 | Jan 2010 | KR |
99925410 | May 1999 | WO |
200050121 | Aug 2000 | WO |
0076568 | Dec 2000 | WO |
2004022145 | Mar 2004 | WO |
2008011683 | Jan 2008 | WO |
2008137644 | Nov 2008 | WO |
2014120492 | Aug 2014 | WO |
Entry |
---|
International Search Report and Written Opinion for corresponding Application No. PCT/US2016/047121, dated Nov. 17, 2016, 11 pages. |
European Search Report for corresponding Application No. 14746739.3-1662, dated Aug. 17, 2016, 9 pages. |
Chinese Office Action and English translation for corresponding Application No. 201480017575.2, dated Sep. 1, 2016, 16 pages. |
www.cpaptalk.com, May 6, 2005-Nov. 30, 2005. |
International Search Report for the corresponding International Application No. PCT/US2009/045256 dated Jul. 20, 2009. |
International Preliminary Report on Patentability and Written Opinion for PCT/US2009/045256 dated Dec. 9, 2010. |
Japanese Patent and Trademark Office, Notice of Rejection for Japanese Patent Application No. 2011-511770 dated Jul. 22, 2014. |
English Summary of Notice of Rejection for Japanese Patent Application No. 2011-511770 dated Jul. 22, 2014. |
Korean Intellectual Property Office, International Search Report and the Written Opinion for the corresponding International Application No. PCT/US2014/012163 dated May 7, 2014. |
“Mirage Micro Nasal Mask”, ResMed, 2007, from www.resmed.com. |
(2006), CPAP Community—View Topic—Mask Gasket [Web log post]. Retrieved from http://www.cpaptalk.com/viewtopic. |
(2006), CPAP Community—View Topic—Mask Experiment Success [Web log post]. Retrieved from http://www.cpaptalk.com/viewtopic. |
(2005-2011), CPAP Community—View Topic—Directions for Toilet Seat Covering [Web log post]. Retrieved from http://www.cpaptalk.com/viewtopic. |
“Pad a Cheek”, PAC_OptiLife, from http://www.padacheek.com/PAC_Maskliner.html, obtained from www.archive.org, published at least as early as Apr. 8, 2012. |
(Nov. 22, 2007), CPAP Community, “Deconstructed Aura” [Web log post]. Retrieved from http://www.cpaptalk.com/viewtopic. |
(2007), CPAP Community, “Decapitating a Twilite NP Mask” [Web log post]. Retrieved from http://cpaptalk.com/viewtopic. |
(2007), CPAP Community, by Wulfman [Web log post]. Retrieved from http://cpaptalk.com/viewtopic. |
(Nov. 30, 2007), CPAP Community, “what is wrong with me” [Web log post]. Retrieved from http://www.cpaptalk.com/viewtopic. |
(Dec. 12, 2008), CPAP Community, “Any one tried a mask cover-gasket” [Web log post]. Retrieved from http://www.cpaptalk.com/viewtopic. |
(2005), CPAP Community, “As long as I don't wake up” [Web log post]. Retrieved from http://www.cpaptalk.com/viewtopic. |
European Search Report for Application No. 09755675.7, dated Nov. 16, 2017, 10 pages. |
Number | Date | Country | |
---|---|---|---|
20150352307 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
61056893 | May 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13758783 | Feb 2013 | US |
Child | 14831371 | US | |
Parent | 12469998 | May 2009 | US |
Child | 13758783 | US |